According to Globes, Israel’s Dune Medical Devices Ltd., has been awarded the 2007 Frost & Sullivan European Technology Innovation of the Year Award for its intraoperative breast cancer probe. The device, that was covered by Medgadget before, functions on technology that was designed to analyze differences in electrical waveforms reflected from malignant and benign breast tissues.
Here’s what Frost & Sullivan says about the device:
“Dune’s real-time tissue probe and portable console have the potential to satisfy a major unmet surgical oncology need,” notes Frost & Sullivan Research Director Girish Solanki. “The device provides doctors with simple, real-time determination of margin malignancy status at the desired locus while the patient is still in the operating room. It helps improve surgical accuracy, allowing doctors to meet procedure goals more easily without the need for a second surgery.”
“Today, breast conservation surgery aims to excise tumors completely, along with a rim of surrounding healthy tissue. However, determining the status of this tissue is difficult, and a large number of women must undergo a re-excision to achieve desired surgical results. This is because an accurate and reliable method for accessing margin status intraoperatively has not existed until now. The Dune probe fills an important need,” adds Solanki.
A recent study found that the Dune probe detected 86 percent of positive tumor margins that were otherwise missed by current standard of care, potentially allowing surgeons to reshave the tumor cavity and eliminate an additional surgery. In a second recent study, the device identified 2O out of 21 DCIS sites as verified by post-operative pathology reports. DCIS is a hard-to-detect non-invasive form of breast cancer.
“Among the probe’s multiple advantages are intraoperative detection of positive resection margins in breast conservation surgery and the quantification of dozens of measurement points within minutes, along with simple operation supporting current breast surgical workflow,” says Solanki.
Venture capital investments from Apax Partners and other investors have allowed Dune Medical to advance its technology development and obtain regulatory certifications such as the CE mark for marketing in Europe.
Flashbacks: Dune Medical BP Probe for Breast CA
Press release: Dune Medical Devices Honored With 2007 Frost & Sullivan European Technology Innovation of the Year Award for Novel Cancer Probe …
Globes: Dune Medical wins Frost & Sullivan award …
